Where is Tilda Bio located?

Tilda Bio is headquartered in San Francisco, United States.

Who is the current CEO of Tilda Bio?

Ram Yalamanchili of Tilda Bio. They have also founded 1 company.

How many employees does Tilda Bio have?

As of Apr 30, 2026, the latest employee count at Tilda Bio is 70.

Is Tilda Bio a funded company?

Tilda Bio is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Tilda Bio rank among its competitors?

Tilda Bio ranks 9th amongst 185 active competitors, of which 4 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was BioMADE, which secured $2.42M in Aug, 2025.

Tilda Bio - 2026 Company Profile, Team, Funding & Competitors

Q: Who are the top competitors of Tilda Bio?

Tilda Bio's top competitors include Javara Research, Alcanza Clinical Research and The START Center for Cancer Research. Among them, BioMADE secured the most recent funding round in August, 2025.

Tilda Bio is a funded company based in San Francisco (United States), founded in 2017 by Ram Yalamanchili. It operates as a Provider of clinical trial execution services to sponsors and CROs. The company has 185 active competitors, including 4 funded and 25 that have exited. Its top competitors include companies like Javara Research, Alcanza Clinical Research and The START Center for Cancer Research.

Company Details

Provider of clinical trial execution services to sponsors and CROs. The company leverages Patient Recruitment and Enrollment, Regulatory Documentation, data integration, site-wide automation, and real-time monitoring to streamline clinical trials. It also specializes in executing studies across various medical fields, including Alzheimer’s and infectious diseases.

Key Metrics

Founded Year

2017

Location

San Francisco, United States

Stage

Funding Raised

Investors

8VC

Ranked

9^th among 185 active competitors

Employee Count

70 as on Apr 30, 2026

Similar Companies

Javara Research & 229 more

View Tilda Bio's full profile

Tilda Bio is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TILDA RESEARCH INC. CIN: 07485730 , United States, Active	Jun 25, 2019	-	-	-
TILDA RESEARCH INC. CIN: 7485730 , United States, Active	Jun 25, 2019	-	2 (As on Jan 31, 2020)	-

Tilda Bio is a funded company. Tilda Bio has 1 institutional investor.

View details of Tilda Bio's funding rounds and investors

The founders of Tilda Bio is Ram Yalamanchili. Ram Yalamanchili is the CEO of Tilda Bio.

Here are the details of Tilda Bio's key team members:

Ram Yalamanchili: Founder & CEO of Tilda Bio.
Contact Info: 1 email address

View details of Tilda Bio's Founder profiles and Board Members

Tilda Bio's employee count trend

Tilda Bio has 70 employees as of Apr 26. Here is Tilda Bio's employee count trend over the years:

Uncover Tilda Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Tilda Bio include Javara Research, Alcanza Clinical Research and The START Center for Cancer Research. Here is the list of Top 10 competitors of Tilda Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Javara Research 2018, Winston-salem (United States), Series B	Integrating clinical research at the point of care for better outcomes	$45M	General Atlantic, FCA Venture Partners & 1 others	56/100
2nd	Alcanza Clinical Research 2021, Methuen (United States), Funding Raised	Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation	-	Impact Engine, Martis Capital	43/100
3rd	The START Center for Cancer Research 2007, San Antonio (United States), Series B	Provider of early-phase oncology clinical trials and research services	$16.9M	Warburg Pincus	42/100
4th	Vial 2020, San Francisco (United States), Series B	-	$100M	General Catalyst, BoxGroup & 1 others	42/100
5th	SMO ClinPlus 2009, Huangpu (China), Public	Provider of clinical trial and clinical research services for biopharma sector	-	TF Capital, HM Venture Partners	41/100
6th	Care Access 1998, Boston (United States), Unfunded	CRO offering clinical sites which conduct clinical trials	-	-	40/100
7th	Sampled 1999, Motherwell (United Kingdom), Funding Raised	Provider of smart laboratory services for drug developers	-	Pioneer Group	40/100
8th	Elite Clinical Network 1996, Las Vegas (United States), Funding Raised	Dedicated network of clinical research sites offering a wide range of research specialties	-	Surge Private Equity, MGG Investment Group	38/100
9th	Tilda Bio 2017, San Francisco (United States), Funding Raised	Provider of clinical trial execution services to sponsors and CROs	-	8VC	37/100
10th	BioMADE 2020, Saint Paul (United States), Funding Raised	Provider of clinical trial research site services for biopharma sector	-	National Science Foundation	37/100